ArticleEuropean journal of pharmacology2021

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.

Krishnaprasad Baby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.